Navigation Links
Ranbaxy gets US FDA approval for Lisinopril

Ranbaxy Pharmaceuticals Inc (RPI) has received a tentative approval from the US FDA for Lisinopril tablets. Lisinopril is recommended for hypertension, either alone for initial therapy or with other classes of anti-hypertenive agents. It is also used as adjunctive therapy in the management of heart failure and patients who do not respond to diuretics. //

However it expects to launch the product only in June 2002, when the original patent expires on the drug, Zestril. Zestril is a registered trademark of Astra Zeneca UK Ltd. A wholly-owned subsidiary of Ranbaxy Laboratories Ltd, RPI expects to be able to access retail pharmacy outlets, wholesalers, hospitals and generic distributors in the US, only post - June 2002.

Sales in 2000 for Lisinopril touched $ 1.2 billion. It is sold under two brands in the US market , of which Zestril alone sold $ 0.66 billion in 2000. The tentative approval has been given for a single entity form of Lisinopril. An Abbreviated New Drug Application (ANDA) submission by Ranbaxy, for Lisinopril and Hydrochlorithizide is still outstanding and pending approval from the US FDA.

The tentative US FDA approval has been given for Lisinopril tablets USP 2.5 mg, 5 mg, 10 mg 20 mg and 40 mg. Based on kinetic studies, it has been deemed to be a bio-equivalent and therapeutically equivalent to Zestril tablets. The tentatively approved formulation is the result of R&D efforts that focussed on the Active Pharmaceutical Ingredient and the bio-equivalent formulation, both of which were developed in-house.


'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy Labs Entry Into Anti-Acne Market
3. Ranbaxy trying to make inroads in herbal drugs market
4. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
(Date:11/21/2008)...OWN, W.Va., Nov. 21 New...ng whether a smokeless, spitless tobacco product a...rchers have found that RJ Reynolds, Camel Snus - t...ction - contains surprisingly high levels of nicot... than most other snuff products," said Bruce Adkin...
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
(Date:11/21/2008)...E, N.J., Nov. 21 Barr Ph... that its shareholders overwhelmingly approved the...sition of Barr by Teva Pharmaceuticals Industries ...demonstrated the overwhelming support of the trans...wney, Barr,s Chairman and CEO. "We are pleased wit...
(Date:11/21/2008)...0 B.C., a new and deadly diseaseits cause remains ...state was teeming with citizens, soldiers and refu...rta. As streets filled with corpses, social order ... returned twice and Athens lost a third of its pop... marked the beginning of the end of the Golden Age...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...re most likely to gain weight, a new study says//....n 2,300 girls aged nine and 10 and followed them f...height, weight, blood pressure and cholesterol eve...n had the teens report their own measures at ages ...
...y became the first in the country to win a new gov... quality patient care. The National Accreditation...(NABH) certification "is an endorsement of our foc..., the hospital's chief operating officer, told IAN...
...ily of enzymes called sirtuins, which can dramatic...t, worms, and flies. Now, a new study from scient...ategy for activating sirtuins to unleash their ant...to control age-associated metabolic disorders, inc...
...e marijuana is not easy as it results in withdrawa...ly in life the usage started. Marijuana, a mixtur... plant, Cannabis sativa, is smoked as a cigarette ...annabinol) is the main active chemical present in ...
Other Medicine News:Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Anti-Aging Powers of Enzyme Sirtuins 2
(Date:11/20/2008)...wire/ -- Epeius Biotechnologies,announced today t... in,chemotherapy-resistant metastatic soft tissue...nt P. Chawla, principal investigator, at the CTOS ...r 13-15, 2008. Patients received,repeated infusio...nalysis of,safety and efficacy data showed no maj...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...linical data from a prospective,registry presente...ws DVT,treatment with the Trellis(R) Peripheral I... Clara, CA) successfully breaks up the blood clot ...is technique, called isolated pharmacomechanical t... safely than current catheter-directed thrombolysi...
(Date:11/19/2008)...tatistical significance , , ISELIN, N.J., N...ion (Nasdaq: PARS ) today announced results from...ulsion (NE) drug delivery technology formulated wi...lti-center, randomized, double-blinded, placebo-co...f the Company,s 3% Diclofenac Diethanolamine NanoE...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Off Hours Heart Patients Less Likely to Get Angioplasty 17343 1Off Hours Heart Patients Less Likely to Get Angioplasty 17343 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 1Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 3Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 4Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 1Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 2Crop management strategies key to a healthy Gulf planet 2980 1Crop management strategies key to a healthy Gulf planet 2980 2Crop management strategies key to a healthy Gulf planet 2980 3
...ong ADHD Patients Nearly Triple That,of General Po..., INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall...ttera(R) (atomoxetine HCl),improved symptoms of At...patients with comorbid alcohol abuse disorder, sug... with Strattera in,patients with both disorders. R...
...ty Demonstrated Among Patients with,Active Disease... --,ChemoCentryx, Inc., a clinical-stage biopharma...g and commercializing,orally-administered therapeu...ata today from the company,s Phase 2 clinical tria...-inflammatory agent,that targets the chemokine rec...
Other Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5
Bio-Rad's Model 1575 immunowash microplate washer offers complete control of needle position to perform special wash routines and maximize wash efficiency. This system includes a large choice of wash
LHW is a solid made, manual plate washer for low throughput use. Separate valves for dispense and aspirate function ensure proper washing results. LHW8 comes complete with a stand and all necessary t
MW 96-W1 microplate washer with one wash line.
Full automatic, ready-to-use strip washer.
Medicine Products: